Kathy LaPorte

Kathy LaPorte

Director/Board Member presso PRECIPIO, INC.

Patrimonio netto: 92 194 $ in data 31/03/2024

62 anni
Health Technology
Finance
Health Services

Profilo

Kathy D.
LaPorte
was the founder of New Leaf Venture Partners LLC, which was founded in 2005.
She held the title of Partner at the firm.
Ms. LaPorte is also the founder of HealthTech Capital Co. Ms. LaPorte's current job(s) include being a Director at Aesthetic Sciences Corp., Precipio Diagnostics LLC, Bolt Biotherapeutics, Inc., Precipio, Inc., Elysium Therapeutics, Inc., 89bio, Inc., Q32 Bio, Inc. (Massachusetts), D2G Oncology, Inc., and CERo Therapeutics Holdings, Inc. She is also a Director at Q32 Bio, Inc.Ms. LaPorte's former job(s) include being the Chief Executive Officer at Nodality, Inc. from 2015 to 2016.
She was also a Director at Cytyc Prenatal Products Corp., Onyx Pharmaceuticals, Inc., ISTA Pharmaceuticals, Inc., VNUS Medical Technologies, Inc., Transcept Pharmaceuticals, Inc. (Old), eHealth, Inc., Affymax, Inc., Cellgate, Inc., Prometheus Laboratories, Inc., eHealthInsurance Services, Inc., California Institute for Regenerative Medicine, Pearl Therapeutics, Inc., Transcept Pharma, Inc., Phoenix Biotech Acquisition Corp., and First Boston Corp.
She was a General Partner at Sprout Group from 1993 to 2004 and a Principal at Asset Management Co. from 1987 to 1992.
She was also a Partner at New Leaf Venture Partners LLC from 2005 to 2011 and a General Partner at Credit Suisse Securities (USA) LLC in 2005.
Additionally, she served as the President of the Western Association of Venture Capitalists.
Ms. LaPorte's education includes an undergraduate degree from Yale University in 1983 and an MBA from Stanford Graduate School of Business in 1987.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
15/04/2024 10 071 ( 0.71% ) 67 476 $ 31/03/2024
0.04%
05/04/2024 5 828 ( 0.04% ) 17 892 $ 31/03/2024
0.00%
25/03/2024 302 ( 0.00% ) 5 146 $ 31/03/2024
12/06/2023 1 200 ( 0.00% ) 1 680 $ 31/03/2024
01/02/2024 0 ( -.--% ) - $ 31/03/2024

Posizioni attive di Kathy LaPorte

SocietàPosizioneInizio
PRECIPIO, INC. Director/Board Member 09/08/2018
BOLT BIOTHERAPEUTICS, INC. Director/Board Member 01/12/2020
89BIO, INC. Director/Board Member 01/11/2021
Director/Board Member 01/08/2016
Director/Board Member 01/01/2020
Director/Board Member 03/08/2021
Director/Board Member -
Director/Board Member -
Tutte le posizioni attive di Kathy LaPorte

Precedenti posizioni note di Kathy LaPorte

SocietàPosizioneFine
California Institute for Regenerative Medicine Director/Board Member 01/09/2017
░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Kathy LaPorte

Formazione di Kathy LaPorte

Yale University Undergraduate Degree
Stanford Graduate School of Business Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Kathy LaPorte

Relazioni

100 +

Relazioni di 1° grado

32

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa5
EHEALTH, INC.

Finance

AFFYMAX, INC.

Health Technology

BOLT BIOTHERAPEUTICS, INC.

Health Technology

PRECIPIO, INC.

Health Services

89BIO, INC.

Health Technology

Aziende private25
First Boston Corp.

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Finance

Health Technology

Finance

Health Technology

Finance

Finance

Finance

California Institute for Regenerative Medicine

Government

Western Association of Venture Capitalists

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Finance

Vedi le connessioni aziendali